Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients

Details for Australian Patent Application No. 2004260624 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Steinborn, Claus; Beckmann, Katrin; Straub, Matthias; Cautreels, Werner; Jansen, Johannes Wilhelmus Catherine Maria

Agent Watermark

Pub. Number AU-A-2004260624

PCT Pub. Number WO2005/011690

Priority 03102243.7 21.07.03 EP

Filing date 19 July 2004

Wipo publication date 10 February 2005

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/4995 (2006.01) - Pyrazines or piperazines forming part of bridged ring systems

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/011690 Priority application(s): WO2005/011690

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260625-Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof

2004260620-Sealing of bacterial ghosts by means of bioaffinity interactions